Literature DB >> 10549534

Mammalian in vitro splicing assays.

A Mayeda1, A R Krainer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10549534     DOI： 10.1385/1-59259-676-2:315

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  40 in total

1.  Functions of SR proteins in the U12-dependent AT-AC pre-mRNA splicing pathway.

Authors:  M L Hastings; A R Krainer
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

2.  Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch.

Authors:  Victor C Hou; Robert Lersch; Sherry L Gee; Julie L Ponthier; Annie J Lo; Michael Wu; Chris W Turck; Mark Koury; Adrian R Krainer; Akila Mayeda; John G Conboy
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

3.  The WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivo.

Authors:  Kai-Ti Lin; Ruei-Min Lu; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

4.  Contribution of DEAH-box protein DHX16 in human pre-mRNA splicing.

Authors:  Marieta Gencheva; Mitsuo Kato; Alain N S Newo; Ren-Jang Lin
Journal:  Biochem J       Date:  2010-07-01       Impact factor: 3.857

5.  Determinants of the inherent strength of human 5' splice sites.

Authors:  Xavier Roca; Ravi Sachidanandam; Adrian R Krainer
Journal:  RNA       Date:  2005-05       Impact factor: 4.942

6.  Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics.

Authors:  Xavier Roca; Andrew J Olson; Atmakuri R Rao; Espen Enerly; Vessela N Kristensen; Anne-Lise Børresen-Dale; Brage S Andresen; Adrian R Krainer; Ravi Sachidanandam
Journal:  Genome Res       Date:  2007-11-21       Impact factor: 9.043

7.  Splicing remodels messenger ribonucleoprotein architecture via eIF4A3-dependent and -independent recruitment of exon junction complex components.

Authors:  Zuo Zhang; Adrian R Krainer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-02       Impact factor: 11.205

8.  Alternative splicing as a therapeutic target for human diseases.

Authors:  Kenneth J Dery; Veronica Gusti; Shikha Gaur; John E Shively; Yun Yen; Rajesh K Gaur
Journal:  Methods Mol Biol       Date:  2009

9.  Exonic splicing enhancer motif recognized by human SC35 under splicing conditions.

Authors:  H X Liu; S L Chew; L Cartegni; M Q Zhang; A R Krainer
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 10.  Assays for the identification and prioritization of drug candidates for spinal muscular atrophy.

Authors:  Jonathan J Cherry; Dione T Kobayashi; Maureen M Lynes; Nikolai N Naryshkin; Francesco Danilo Tiziano; Phillip G Zaworski; Lee L Rubin; Jill Jarecki
Journal:  Assay Drug Dev Technol       Date:  2014-08       Impact factor: 1.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.